Intracellular Plutonium: Removal by Liposome-Encapsulated Chelating Agent

Chelating agents, such as ethylenediaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA) were successfully encapsulated within lipid spherules (that is, liposomes). Encapsutlated [14C]EDTA, given intravenously to mice, was retained longer in tissues that nonencapsulated [14C]EDTA. Encapsulated DTPA, given to mice 3 days after pluttonium injection, removed an additional fraction of plutonium in the liver, presumably intracellular, not available to nonencapslulated DTPA. It also further increased urinary excretion of plutonium. Introduction of chelating agents into cells by liposomal encapsulation is a promising new approach to the treatment of metal poisoning

[1]  G. Gregoriadis,et al.  Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. , 1972, The Biochemical journal.

[2]  J. Schubert,et al.  Progress report: plutonium removal. IV. Tissue distribution of monomeric and polymeric plutonium as modified by a chelating agent. , 1960, Annual report - Division of Biological and Medical Research, Argonne National Laboratory. Argonne National Laboratory. Division of Biological and Medical Research.

[3]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[4]  J F MARKLEY,et al.  REMOVAL OF POLYMERIC PLUTONIUM FROM MICE BY COMBINED THERAPY WITH THE CALCIUM CHELATE AND PENTA-ETHYL ESTER OF DTPA. , 1963, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[5]  W. Langham,et al.  Plutonium accumulation from long-term occupational exposure. , 1960, Health physics.

[6]  B. Stover,et al.  Protracted hepatic, splenic and renal retention of 239 Pu in the beagle. , 1971, Health physics.

[7]  B. Stover,et al.  Liver injury in beagles with Pu-239: distribution, dosage and damage. , 1962, Health physics.

[8]  C. W. Mays,et al.  Speculated risk to bone and liver from 239 Pu. , 1970, Health physics.

[9]  Belknap El.  EDTA in the treatment of lead poisoning. , 1952 .

[10]  A. Catsch.  Dekorporation von radionukliden durch veresterte Polyaminopolycarbonsäuren , 1961 .

[11]  A. Lindenbaum,et al.  Marrow deposition and distribution of monomeric and polymeric 239 Pu in the mouse, estimated by use of 59 Fe. , 1972, Health physics.

[12]  H. Hart,et al.  Excretion of Yttrium and Lanthanum Chelates of Cyclohexane 1,2-Trans Diamine Tetraacetic Acid and Diethylenetriamine Pentaacetic Acid in Man , 1957, Nature.

[13]  A. Lindenbaum,et al.  Colloidal properties of plutonium in dilute aqueous solution , 1965 .

[14]  A. Lindenbaum,et al.  Deposition patterns and toxicity of plutonium and americium in liver. , 1972, Health physics.

[15]  Y. Rahman,et al.  LYSOSOME PARTICLES AND SUBCELLULAR DISTRIBUTIONS OF POLYMERIC TETRAVALENT PLUTONIUM-239. , 1964, Radiation research.

[16]  R. L. Huff,et al.  Use of a Chelating Agent for Accelerating Excretion of Radio-Iron , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.